Quick Takeaways: Why It Matters? Cronus Pharma’s launch of Robenacoxib Injection gives US veterinarians the first FDA‑approved bioequivalent to Onsior (robenacoxib) Injection, providing a cost‑effective, short‑term NSAID option for postoperative pain an...
Quick Takeaways: Why It Matters? The launch should help Zomedica make PulseVet easier to use in everyday practice by improving patient and staff comfort, potentially reducing anxiety-driven resistance and making clinics more willing to adopt or keep using shock wave therapy for equine and ...
